Cargando…
Mir‐1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53
BACKGROUND: Many chemotherapy regimens are used to treat breast cancer; however, breast cancer cells often develop drug resistance that usually leads to relapse and poor prognosis. MicroRNAs (miRNAs) are short non‐coding RNA molecules that post‐transcriptionally regulate gene expression and play cru...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983221/ https://www.ncbi.nlm.nih.gov/pubmed/29697201 http://dx.doi.org/10.1111/1759-7714.12607 |